Welcome to DNKO
DNKO, led by advocates, scientists and clinicians for patients with brain cancer and their families.
We kindly invite you to read through this whole site.
Our next milestone is to raise $250,000 for a preclinical pig study that will inform a clinical canine glioma study; the next stop is a Phase I in patients.
Co-Founder & CEO
David Needham PhD, DSc
Co-Founder & CSO
DNKO thrives on resonant collaboration and transparency. Please don't hesitate to contact us regarding any form of inquiry:
Kate@DNKO.net Co-Founder & CEO
David@DNKO.net Co-Founder & CSO
We're particularly interested in collaborating with people who have interest and/or expertise in:
Marketing & Communications
Clinical collaborators using LITT
Preclinical and clinical research for brain cancers and other cancers in general